The True Image Solution Ltd. is a research company established in 2013. Their main focus is the non-destructive evaluation of objects of art and cultural heritage, as well as research towards the development of new techniques and adapting existing techniques to this field. True Image Solution implements the latest technology and techniques as they are developed by the most renowned art experts all over the world. The main goal of the company is to provide customers with state of the art professional services in the field of analysis and pre-restoration diagnostics of objects of fine arts and cultural heritage such as paintings, wood panels, icons, statues, frescoes, etc.
High-resolution light, electron and AFM microscopy
Near- and Shortwave Infrared imaging
Ultrasonic imaging and Acoustic microscopy
Fourier-transform Infrared spectroscopy
Mathematical methods for the analysis of craquelure, canvas cuspings and canvas density
Encryption and digital fingerprinting methods for art object protection
X-ray fluorescence spectroscopy
Hamilton Kerr Institute, University of Cambridge
The Courtauld Institute of Art
Tessonics Medical Systems Inc, (TMS) is developing innovative diagnostic instrumentation solutions to increase medical readiness, mitigate fatalities, optimally treat life-threatening injuries, and promote positive long-term outcomes.
TMS currently focuses on further development and commercialization of the Transcranial Ultrasound Brain Imaging (TRUBI) technology that has been originally developed by Tessonics Corporation during the past decade. TMS aims to implement the TRUBI technology in an advanced ultrasound diagnostic imaging instrument that will provide a forward-deployable solution for rapid and accurate diagnosis of life-threatening traumatic brain injuries (TBI).
TRUBI is an easy-to-use, ruggedized, portable, lightweight, shock- and impact-resistant device suitable for use in austere combat and civilian environments by medical personnel with all levels of training. TMS has recently conducted a comprehensive preclinical evaluation of the TRUBI prototype instrument and demonstrated its unique performance features capable of greatly enhancing in-theater diagnostics of intracranial hematomas (ICH) associated with TBI. Cutting-edge artificial intelligence (AI) techniques are used to develop algorithms that rapidly and accurately detect ICH in transcranial ultrasound images and accurately determine their types.